Authors: Jana G. Hashash, Jaclyn Elkins, James D. Lewis, and David G. Binion Journal: Gastroenterology Year: 2024 Volume: 166 Pages: 521–532 DOI: 10.1053/j.gastro.2023.11.303 Study at a Glance Study type: Expert review Participants: Not applicable (expert guidance document) Population studied: Patients with inflammatory bowel disease (IBD) Intervention or approach studied: Diet and nutritional therapies, including Mediterranean […]
Modern Advanced Therapies for Inflammatory Bowel Diseases: Practical Considerations and Positioning
Authors: David I. Fudman, Ryan A. McConnell, Christina Ha, and Siddharth Singh Journal: Clinical Gastroenterology and Hepatology Year: 2025 Volume: 23 Pages: 454–468 DOI: https://doi.org/10.1016/j.cgh.2024.06.050 Study at a Glance Study type: Narrative review Participants: Not applicable Population studied: Patients with inflammatory bowel disease Intervention or approach studied: Janus kinase inhibitors, interleukin-23 antagonists, and sphingosine 1-phosphate […]
Diet in Inflammatory Bowel Diseases: Efficacy, Tolerability, and Microbiome Effects Toward Personalized Management
Francesco Calabrese and colleagues from the University of Genoa have published a comprehensive review examining the role of diet as a potential therapeutic tool in inflammatory bowel disease. Their work, published in Digestive Diseases and Sciences in 2025, explores how various dietary approaches may influence symptoms, intestinal inflammation, the gut microbiome, and mucosal repair in […]
New medicine for Crohn’s disease shows early promise in clinical trial
A new medicine called duvakitug has shown encouraging results in an early clinical trial for people with Crohn’s disease, according to findings published in The Lancet Gastroenterology & Hepatology. The study, known as RELIEVE UCCD, tested whether the drug could help control inflammation and symptoms in people living with the condition. Whilst the results are […]
The Mediterranean Diet and Inflammatory Bowel Disease: A Comprehensive Systematic Review and Meta-Analysis
Authors: Muhammad Shahzil, Syeda Kanza Kazmi, Minahel Shehzadi, Fariha Hasan, Mohammad Waqas Danish, Muhammad Saad Faisal, Justin Canakis, Kofi Clarke Journal: Gastroenterology Research and Practice Year: 2026 Volume: 2026 **Article…
Epidemiology, pathogenesis, diagnosis, and treatment of inflammatory bowel disease: Insights from the past two years
Article information Authors: Jian Wan, Jiaming Zhou, Zhuo Wang, Dan Liu, Hao Zhang, Shengmao Xie, Kaichun Wu Journal: Chinese Medical Journal Year: 2025 Volume: 138 Issue: 7 Pages: 763-776…
Nutritional composition of diets for inducing and maintaining remission in inflammatory bowel diseases: from bedside to plate
Article information Authors: L. Godny, T. Pfeffer-Gik, S. Elial-Fatal, S. Shakhman, I. Dotan Journal: Current Opinion in Pharmacology Year: 2026 Volume: 86 Article number: 102587 DOI: https://doi.org/10.1016/j.coph.2025.102587 Study…
JAK inhibitor shows promise for perianal Crohn’s disease in real-world study
A medicine already used to treat inflammatory bowel disease (IBD) may help people with a difficult form of Crohn’s disease affecting the area around the anus, according to research published…
Crohn’s vs. Ulcerative Colitis: What’s Actually the Difference?
Two conditions, one umbrella Both Crohn’s disease and ulcerative colitis sit under the term inflammatory bowel disease, or IBD. They share much in common: long-term gut inflammation, unpredictable flare-ups,…